ACHL logo

Achilles Therapeutics (ACHL)

Profile

Full Name

Achilles Therapeutics plc

Ticker Symbol

ACHL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

March 31, 2021

Indexes

Not included

Website

http://www.achillestx.com

Employees

204

Key Details

Price

$1.48

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$1.74(+4.40% YoY)

PE Ratio

-

Next earnings date

Apr 4, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.48
ACHL price is $1.48

Price All-time High

$17.86
ACHL price is currently -91.71% below its historical high of $17.86

Price Most Recent Change

-
ACHL price change on Mar 24, 2025 is unknown

Price YTD Change

+29.82%
ACHL price is up +29.82% since January 1st

Price 1-year Change

+29.82%
ACHL price is up +29.82% year-on-year

Price 3-year Change

-50.34%
ACHL price is down -50.34% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$60.83M
ACHL market capitalization is $60.83 million

Market Cap 3-year Change

-49.91%
ACHL market capitalization is down -49.91% over the past 3 years

Market Cap All-time High

$725.51M
ACHL market capitalization is currently -91.62% below its historical high of $725.51 million

Market Cap Sector Rank

40.85%
ACHL market capitalization is higher than 40.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-3.76%
ACHL shares outstanding is down -3.76% year-on-year

Shares Outstanding 3-Year Change

+0.85%
ACHL shares outstanding is up +0.85% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.94
ACHL beta is 0.94

200-day SMA

$1.02
ACHL price is currently +45.11% above its 200-day simple moving average

50-day SMA

$1.32
ACHL price is currently +12.11% above its 50-day simple moving average

RSI

75.21
ACHL 14-day relative strength index is 75.21

Volume

0.00
ACHL 30-day relative volume is 0.00

ATR

$0.01
ACHL average true range is $0.01

10-day Historical Volatility

20.86%
ACHL 10-day historical volatility is 20.86%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ACHL annual revenue value is unknown

Revenue Analysts Estimate

-
ACHL annual revenue consensus analysts' forecast is unknown

Revenue 1-year Change

-
ACHL annual revenue 1-year change is unknown

Revenue Sector Rank

-
ACHL annual revenue is unknown

EPS

EPS

-$1.74
ACHL annual earnings per share is -$1.74

EPS Analysts Estimate

-$0.18
ACHL annual earnings per share is currently +866.67% higher than the consensus analysts' forecast

EPS 1-year Change

+4.4%
ACHL annual earnings per share is up +4.4% year-on-year

EPS Sector Rank

41.34%
ACHL annual earnings per share is higher than 41.34% of companies in Healthcare sector

Profit

Gross Profit

-
ACHL annual gross profit value is unknown

Gross Margin

-
ACHL annual gross profit margin value is unknown

Operating Profit

-$75.25M
ACHL annual operating income is -$75.25 million

Operating Margin

-
ACHL annual operating profit margin value is unknown

Net Income

-$69.67M
ACHL annual net profit is -$69.67 million

Net Margin

-
ACHL annual net profit margin value is unknown

Expenses

Total Expenses

$75.25M
ACHL annual total expenses is $75.25 million

Operating Expenses

$75.25M
ACHL annual total operating expenses is $75.25 million

Cost Of Goods Sold

-
ACHL annual cost of goods sold value is unknown

Selling, General & Administrative Expenses

$17.01M
ACHL annual SGA is $17.01 million

Depreciation And Amortization

$4.71M
ACHL annual depreciation & amortization is $4.71 million

Interest Expense

-
ACHL annual interest expense value is unknown

Income Tax

$491.00K
ACHL annual income tax is $491.00 thousand

EBIT & EBITDA

EBIT

-$75.25M
ACHL annual earnings before interest & taxes is -$75.25 million

EBITDA

-$70.54M
ACHL annual EBITDA is -$70.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$161.46M
ACHL annual total assets is $161.46 million

Non Current Assets

$15.82M
ACHL annual long term assets is $15.82 million

Current Assets

$145.63M
ACHL annual total current assets is $145.63 million

Cash And Cash Equivalents

$131.54M
ACHL annual cash & cash equivalents is $131.54 million

Accounts Receivable

-
ACHL annual accounts receivable value is unknown

Inventory

-
ACHL annual inventory value is unknown

Liabilities

Total Liabilities

$19.09M
ACHL annual total liabilities is $19.09 million

Long Term Liabilities

$2.09M
ACHL annual total long term liabilities is $2.09 million

Current Liabilities

$17.00M
ACHL annual total current liabilities is $17.00 million

Accounts Payable

$5.63M
ACHL annual accounts payable is $5.63 million

Debt

Total Debt

$4.62M
ACHL annual total debt is $4.62 million

Total Debt 1-year Change

-46.19%
ACHL annual total debt is down -46.19% year-on-year

Long Term Debt

$1.08M
ACHL annual long term debt is $1.08 million

Short Term Debt

$3.54M
ACHL annual short term debt is $3.54 million

Equity & Capital

Shareholders Equity

$142.37M
ACHL annual stockholders equity is $142.37 million

Book Value

$142.37M
ACHL annual book value is $142.37 million

Retained Earnings

-$259.95M
ACHL annual retained earnings is -$259.95 million

Working Capital

$128.64M
ACHL annual working capital is $128.64 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$48.45M
ACHL annual cash flow from operations is -$48.45 million

Cash From Operations 1-year Change

+18.62%
ACHL annual cash flow from operations is up +18.62% year-on-year

Cash From Investing

-$1.10M
ACHL annual cash flow from investing activities is -$1.10 million

Cash From Investing 1-year Change

+85.36%
ACHL annual cash flow from investing activities is up +85.36% year-on-year

Cash From Financing

$9000.00
ACHL annual cash flow from financing activities is $9000.00

Cash From Financing 1-year Change

+800%
ACHL annual cash flow from financing activities is up +800% year-on-year

CAPEX

CAPEX

-
ACHL annual capital expenditures value is unknown

CAPEX 1-year Change

-
ACHL annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

-$49.55M
ACHL annual free cash flow is -$49.55 million

Free Cash Flow 1-year Change

+26.1%
ACHL annual free cash flow is up +26.1% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

-
ACHL annual gross profit margin value is unknown

Operating Margin

-
ACHL annual operating profit margin value is unknown

Net Margin

-
ACHL annual net profit margin value is unknown

ROA & ROE

ROA

-43.15%
ACHL annual return on assets is -43.15%

ROE

-48.93%
ACHL annual return on equity is -48.93%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
ACHL price to earnings ratio value is unknown

PE Ratio Sector Rank

-
ACHL price to earnings ratio is unknown

PB Ratio

PB Ratio

0.59
ACHL price to book ratio is 0.59

PB Ratio Sector Rank

33.25%
ACHL price to book ratio is higher than 33.25% of companies in Healthcare sector

PS Ratio

PS Ratio

-
ACHL price to sales ratio value is unknown

PS Ratio Sector Rank

-
ACHL price to sales ratio is unknown

Enterprise value

Enterprise Value

-$21.60M
ACHL enterprise value is -$21.60 million

Enterprise Value Sector Rank

3.14%
ACHL enterprise value is higher than 3.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.31
ACHL EV/EBITDA is 0.31

EV/EBITDA Sector Rank

70.25%
ACHL EV/EBITDA is higher than 70.25% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

8.57
ACHL annual current ratio is 8.57

Quick Ratio

-
ACHL annual quick ratio value is unknown

Leverage

Debt To Equity

0.03
ACHL annual debt to equity ratio is 0.03

Interest Coverage Ratio

-
ACHL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ACHL piotroski f-score value is unknown

Altman Z-Score

-
ACHL altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 5, 24 Piper Sandler
Neutral
Apr 5, 24 Chardan Capital
Buy
Dec 14, 23 B of A Securities
Underperform
Aug 7, 23 Chardan Capital
Buy
May 11, 23 Chardan Capital
Buy
Dec 7, 22 Piper Sandler
Overweight
Dec 7, 22 Chardan Capital
Buy
Apr 26, 21 Piper Sandler
Overweight
Apr 26, 21 Oppenheimer
Outperform
Apr 26, 21 JP Morgan
Underweight

Institutional Ownership

Similar stocks

FORA logo
Forian (FORA)
CPIX logo
Cumberland Pharmaceuticals (CPIX)
ACET logo
Adicet Bio (ACET)
VANI logo
Vivani Medical (VANI)
IKNA logo
Ikena Oncology (IKNA)
UNCY logo
Unicycive Therapeutics (UNCY)
ENTX logo
Entera Bio (ENTX)
Cibus (CBUS)
CCLD logo
CareCloud (CCLD)
  • What is the ticker symbol for Achilles Therapeutics?
  • Does Achilles Therapeutics pay dividends?
  • What sector is Achilles Therapeutics in?
  • What industry is Achilles Therapeutics in?
  • What country is Achilles Therapeutics based in?
  • When did Achilles Therapeutics go public?
  • Is Achilles Therapeutics in the S&P 500?
  • Is Achilles Therapeutics in the NASDAQ 100?
  • Is Achilles Therapeutics in the Dow Jones?
  • When was Achilles Therapeutics's last earnings report?
  • When does Achilles Therapeutics report earnings?
  • Should I buy Achilles Therapeutics stock now?

What is the ticker symbol for Achilles Therapeutics?

The ticker symbol for Achilles Therapeutics is NASDAQ:ACHL

Does Achilles Therapeutics pay dividends?

No, Achilles Therapeutics does not pay dividends

What sector is Achilles Therapeutics in?

Achilles Therapeutics is in the Healthcare sector

What industry is Achilles Therapeutics in?

Achilles Therapeutics is in the Biotechnology industry

What country is Achilles Therapeutics based in?

Achilles Therapeutics is headquartered in United Kingdom

When did Achilles Therapeutics go public?

Achilles Therapeutics's initial public offering (IPO) was on March 31, 2021

Is Achilles Therapeutics in the S&P 500?

No, Achilles Therapeutics is not included in the S&P 500 index

Is Achilles Therapeutics in the NASDAQ 100?

No, Achilles Therapeutics is not included in the NASDAQ 100 index

Is Achilles Therapeutics in the Dow Jones?

No, Achilles Therapeutics is not included in the Dow Jones index

When was Achilles Therapeutics's last earnings report?

Achilles Therapeutics's most recent earnings report was on Nov 14, 2024

When does Achilles Therapeutics report earnings?

The next expected earnings date for Achilles Therapeutics is Apr 4, 2025

Should I buy Achilles Therapeutics stock now?

As of today, analysts generally recommend a 'Sell' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page